Searching for value in the battered biotech sector, which may not have hit bottom yet
Amid the market turmoil, a growing number of biotech stocks are now trading below the value of the cash on their balance sheets.
Source link
- UN expert demands accelerated probe into Sudan post-coup killings
- These battle-tested stocks offer ‘offense and defense’ in an uncertain market
